6 analysts have expressed a variety of opinions on SI-BONE (NASDAQ:SIBN) over the past quarter, offering a diverse set of opinions from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
3
3
0
0
0
Last 30D
1
0
0
0
0
1M Ago
0
0
0
0
0
2M Ago
1
1
0
0
0
3M Ago
1
2
0
0
0
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $25.67, along with a high estimate of $27.00 and a low estimate of $24.00. Observing a 1.34% increase, the current average has risen from the previous average price target of $25.33.
Decoding Analyst Ratings: A Detailed Look
The analysis of recent analyst actions sheds light on the perception of SI-BONE by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst
Analyst Firm
Action Taken
Rating
Current Price Target
Prior Price Target
David Saxon
Needham
Maintains
Buy
$27.00
-
David Saxon
Needham
Maintains
Buy
$27.00
-
Matt O'Brien
Piper Sandler
Announces
Overweight
$25.00
-
Drew Ranieri
Morgan Stanley
Raises
Overweight
$26.00
$25.00
Ross Osborn
Cantor Fitzgerald
Maintains
Overweight
$25.00
$25.00
Samuel Brodovsky
Truist Securities
Lowers
Buy
$24.00
$26.00
Key Insights:
Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related ...Full story available on Benzinga.com
Benzinga
